Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in RPRX — Royalty Pharma plc

CIK 1423053 MIAMI, FL
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$75,954,664
-$52,656,215 QoQ
Shares Held
1,354,640
-49.5% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#46
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Derivatives in RPRX

reported options exposure · as of Jun 30, 2026
CallValue
$12,767,139
CallShares
227,700
PutValue
$459,774
PutShares
8,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. RPRX ranks #20 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in RPRX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,954,664 1,354,640
2026-06-30 $459,774 8,200
2026-06-30 $12,767,139 227,700
2026-03-31 $10,423,881 217,300
2026-03-31 $1,971,567 41,100
2026-03-31 $128,610,879 2,681,069
2025-12-31 $203,782,143 5,273,865
2025-12-31 $1,912,680 49,500
2025-12-31 $1,441,272 37,300
2025-09-30 $645,624 18,300
2025-09-30 $13,924,063 394,673
2025-09-30 $5,852,952 165,900
2025-06-30 $9,807,366 272,200
2025-06-30 $2,500,482 69,400
2025-06-30 $18,998,186 527,288
2025-03-31 $7,399,601 237,700
2025-03-31 $64,307,606 2,065,776
2025-03-31 $2,073,258 66,600
2024-12-31 $2,655,591 104,100
2024-12-31 $73,927,061 2,897,964
2024-12-31 $1,301,010 51,000
2024-09-30 $2,435,769 86,100
2024-09-30 $376,257 13,300
2024-06-30 $735,723 27,900
2024-06-30 $3,319,983 125,900
2024-03-31 $2,973,800 97,919
2024-03-31 $2,469,081 81,300
2024-03-31 $2,715,078 89,400
2023-12-31 $1,460,680 52,000
2023-12-31 $3,323,047 118,300
2023-12-31 $13,680,391 487,020
2023-09-30 $2,363,894 87,100
2023-09-30 $3,340,418 123,081
2023-09-30 $1,894,372 69,800
2023-06-30 $1,776,772 57,800
2023-06-30 $20,146,134 655,372
2023-06-30 $1,927,398 62,700
2023-03-31 $2,965,269 82,300
2023-03-31 $38,874,712 1,078,954
2023-03-31 $1,949,223 54,100
2022-12-31 $2,379,104 60,200
2022-12-31 $20,231,867 511,940
2022-12-31 $1,829,776 46,300
2022-09-30 $13,498,912 335,961
2022-09-30 $2,647,862 65,900
2022-09-30 $7,883,316 196,200
2022-06-30 $10,556,244 251,100
2022-06-30 $10,923,883 259,845
2022-06-30 $903,860 21,500
2022-03-31 $3,946,648 101,300